Matthew Gubens, MD, MS, is Associate Professor of Medicine at UCSF, where he practices as a thoracic medical oncologist and serves as Medical Director of Thoracic Medical Oncology. He is also Vice Chair of the UCSF Cancer Center Protocol Review and Monitoring Committee. He is particularly active in immunotherapy clinical trials and is the lung cancer liaison to the UCSF Cancer Immunotherapy Program. Dr. Gubens is Chair-Elect of the ASCO Evidence Based Medicine Committee which oversees the ASCO Guidelines program, and he also co-chairs the ASCO Thoracic Guideline Advisory Group. Dr. Gubens serves on the National Comprehensive Cancer Network panels for non-small cell lung cancer, mesothelioma, and thymic malignancies. Dr Gubens completed his BA at Yale, his MS at the Harvard School of Public Health, and his MD at Stanford, and trained in internal medicine residency at UCSF and then medical oncology at Stanford.
Yale University, B.A., 1997, Ethics, Politics and Economics
Harvard School of Public Health, M.S., 2000, Health Policy and Management
Stanford University, M.D., 2005, School of Medicine
University of California, San Francisco, Residency, 2008, School of Medicine - Internal Medicine
Stanford University Fellowship, 2011, School of Medicine - Medical Oncology